NHLBI IN THE PRESS

Gene editing and nanotechnology could lower cholesterol

An NHLBI-funded team of researchers developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes in mice, as reported in Nature Biotechnology. This new technique eliminates the need to use viruses to carry the CRISPR components. It works by deleting and editing genes that cause disease, for instance, a gene that reduces cholesterol.

Media Coverage

|
Vice
  • CRISPR Can Now Edit Genes Using Nanoparticles Instead of Viruses
    • |
    GEN News
  • CRISPR/Cas9 Delivery Goes Nano with Enhanced Guide RNA
    • |
    VOA
  • US Researchers Use Nanotech, Gene Editing to Edit Cholesterol Gene
    • |
    CNBC
  • Gene editing and nanotechnology could lower cholesterol